A three-hybrid approach to scanning the proteome for targets of small molecule kinase inhibitors

Chemistry and Biology

Volumn 11, Issue 2, 2004, Pages 211-223

  Becker, Frank ^a   Murthi, Krishna ^b   Smith, Chase ^b   Come, Jon ^b,c   Costa Roldán, Nuria ^a   Kaufmann, Christine ^a   Hanke, Urs ^a   Degenhart, Carsten ^a   Baumann, Sabine ^a   Wallner, Wolfgang ^a   Huber, Andrea ^a   Dedier, Severine ^a   Dill, Simone ^a   Kinsman, David ^b   Hediger, Mark ^b   Bockovich, Nicholas ^b   Meier Ewert, Sebastian ^a,b   Kluge, Arthur F ^b   Kley, Nikolai ^a,b  

^a GPC Biotech AG   (Germany)

^b GPC Biotech Inc   (United States)

^c VERTEX PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1542290057     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2004.02.001     Document Type: Article

References (42)

1. Licitra E.J., Liu J.O. A three-hybrid system for detecting small ligand-protein receptor interactions. Proc. Natl. Acad. Sci. USA. 93:1996;12817-12821.
2. Tanaka H., Ohshima N., Hidaka H. Isolation of cDNAs encoding cellular drug-binding proteins using a novel expression cloning procedure. drug-western Mol. Pharmacol. 55:1999;356-363.
3. Sche P.P., McKenzie K.M., White J.D., Austin D.J. Display cloning. functional identification of natural product receptors using cDNA-phage display Chem. Biol. 6:1999;707-716.
4. McPherson M., Yang Y., Hammond P.W., Kreider B.L. Drug receptor identification from multiple tissues using cellular-derived mRNA display libraries. Chem. Biol. 9:2002;691-698.
5. Fields S., Song O. A novel genetic system to detect protein-protein interactions. Nature. 340:1989;245-246.
6. Chien C.T., Bartel P., Sternglanz R., Fields S. The two-hybrid system. a method to identify and clone genes for proteins that interact with a protein of interest Proc. Natl. Acad. Sci. USA. 88:1991;9578-9582.
7. Phizicky E., Bastiaens P.I.H., Zhu H., Snyder M., Fields S. Protein analysis on a proteomic scale. Nature. 422:2003;208-215.
8. Schreiber S.L. Chemical genetics resulting from a passion for synthetic organic chemistry. Bioorg. Med. Chem. 6:1998;1127-1152.
9. Clackson T. Regulated gene expression systems. Gene Ther. 7:2000;120-125.
10. Pollock R., Clackson T. Dimerizer-regulated gene expression. Curr. Opin. Biotechnol. 13:2002;459-467.
11. Lin H., Abida W., Sauer R., Cornish V.W. Dexamethasone-methotrexate. an efficient chemical induced of protein dimerization in vivo J. Am. Chem. Soc. 122:2000;4247-4248.
12. Abida W.M., Crater B.T., Althoff E., Lin H., Cornish V.W. Receptor-dependence of the transcription read-out in a small-molecule three-hybrid system. Chembiochem. 3:2002;887-895.
13. Baker K., Sengupta D., Salazar-Jimenez G., Cornish V.W. An optimized dexamethasone-methotrexate yeast 3-hybrid system for high throughput screening of small molecule-protein interactions. Anal. Biochem. 315:2003;134-137.
14. Henthorn D.C., Jaxa-Chamiec A.A., Meldrum E. A GAL4-based yeast three-hybrid system for the identification of small molecule-target protein interactions. Biochem. Pharmacol. 63:2002;1619-1628.
15. Manning G., Whyte D.B., Martiniez R., Hunter T., Sudarsanam S. The protein kinase complement of the human genome. Science. 298:2002;1912-1934.
16. Chang Y.T., Gray N.S., Rosania G.R., Sutherlin D.P., Kwon S., Norman T.C., Sarohia R., Leost M., Meijer L., Schultz P.G. Synthesis and application of functionally diverse 2,6,9-trisubstituted purine library toward the development of functionally diverse CDK inhibitors. Chem. Biol. 6:1999;361-375.
17. Knockaert M., Greengard P., Meijer L. Pharmacological inhibitors of cyclin-dependent kinases. Trends Pharmacol. Sci. 23:2002;417-425.
18. Davies T.G., Bentley J., Arris C.E., Boyle F.T., Curtin N.J., Endicott J.A., Gibson A.E., Golding B.T., Griffin R., Hardcastle I.R.et al. Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor. Nat. Struct. Biol. 9:2002;745-749.
19. Gray N.S., Wodicka L., Thunnissen A.M., Norman T.C., Kwon S., Espinoza F.H., Morgan D.O., Barnes G., LeClerc S., Meijer L.et al. Exploiting chemical libraries, structure, and genomics in the search for new kinase inhibitors. Science. 281:1998;533-538.
20. Knockaert M., Gray N., Damiens E., Chang Y.-T., Grellier P., Grant K., Fergusson D., Mottram J., Soete M., Dubremetz J.-F.et al. Intracellular targets of cyclin-dependent kinase inhibitors. identification by affinity chromatography using immmobilised inhibitors Chem. Biol. 7:2000;411-422.
21. Knockaert M., Lenormand P., Gray N., Schultz P., Pouyssegur J., Meijer L. p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol. Oncogene. 21:2002;6413-6424.
22. De Azevedo W.F., Leclerc S., Meijer L., Havlicek L., Strand M., Kin S.-H. Inhibition of cyclin-dependent kinases by purine analogs. Eur. J. Biochem. 243:1997;518-526.
23. Meijer L., Raymond E. Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials. Acc. Chem. Res. 36:2003;417-425.
24. Fisher P.M., Gianella-Borradori A. CDK inhibitors in clinical development for the treatment of cancer. Expert. Opin. Investig. Drugs. 12:2003;955-970.
25. Meijer L., Borgne A., Mulner O., Chong J.P., Blow J.J., Inagaki N., Inagaki M., Delcros J.G., Moulinoux J.P. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243:1997;527-536.
26. McClue S.J., Blake D., Clarke R., Cowan A., Cummings L., Fisher P.M., MacKenzie M., Melville J., Stewart K., Wang S.et al. Int. J. Cancer. 102:2002;463-468.
27. Nugiel D.A., Etzkorn A.M., Vidwans A., Benfield P.A., Boisclair M., Burton C.R., Cox S., Czerniak P.M., Doleniak D., Seitz S.P. Indenpyrazoles as novel cyclin dependent kinase (CDK) inhibitors. J. Med. Chem. 44:2001;1334-1336.
28. Nugiel D.A., Vidwans A., Etzkorn A.M., Rossi K.A., Benfield P.A., Burton C.R., Cox S., Doleniak D., Seitz S.P. Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 2. Probing the indeno ring substituent pattern. J. Med. Chem. 45:2002;5224-5232.
29. 1. J. Med. Chem. 24:2002;5233-5248.
30. Gray N.S., Detivaud L., Dierig C., Meijer L. ATP-site directed inhibitors of cuclin-dependent kinases. Curr. Med. Chem. 6:1999;859-875.
31. Koide K., Finkelstein J.M., Ball Z., Verdine G.L. A synthetic library of cell-permeable molecules. J. Am. Chem. Soc. 123:2001;398-408.
32. Sadler K.C. Attention, neurons, this CDK could save your life. Trends Cell Biol. 12:2002;214.
33. Monaco E.A. III, Vallano M.L. Cyclin-dependent kinase inhibitors. cancer killer to neuronal guardians Curr. Med. Chem. 10:2003;367-379.
34. Samuels B.A., Tsai L.H. Cdk5 is a dynamo at the synapse. Nat. Cell Biol. 5:2003;689-690.
35. Estojak J., Brent R., Golemis E.A. Correlation of two-hybrid affinity data with in vitro measurements. Mol. Cell. Biol. 15:1995;5820-5829.
36. Kaiser C., Michaelis S., Mitchell A. Methods in Yeast Genetics. 1994;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
37. Gietz R.D., Woods R.A. Transformation of yeast by lithium acetate/single-stranded carrier DNA/polyethylene glycol method. Methods Enzymol. 350:2002;87-96.
38. Romero F., Dargemont C., Pozo F., Reeves W.H., Camonis J., Gisselbrecht S., Fischer S. p95vav associates with the nuclear protein Ku-70. Mol. Cell. Biol. 16:1996;37-44.
39. Baker K., Bleczinski C., Lin H., Salazar-Jimenez G., Sengupta D., Krane S., Cornish V.W. Chemical complementation. a reaction-independent genetic assay for enzyme catalysis Proc. Natl. Acad. Sci. USA. 99:2002;16537-16542.
40. Wanker E.E., Rovira C., Scherzinger E., Hasenbank R., Wälter S., Tait D., Colicelli J., Lehrach H. Hip-i. A huntingtin interacting protein isolated by the yeast-two hybrid system Hum. Mol. Genet. 6:1997;487-495.
41. Han L., Colicelli J. A human protein selected for interference with Ras function interacts directly with Ras and competes with Raf1. Mol. Cell. Biol. 15:1995;1318-1323.
42. Kaeufer N.F., Fried H.M., Schwindiger W.F., Jasin M., Warener J.R. Cycloheximide resistance in yeast. the gene and its protein Nucleic Acids Res. 11:1983;3123-3135.